Misdiagnosis of soft tissue sarcomas of the lower limb associated with deep venous thrombosis: report of two cases and review of the literature
© Perisano et al.; licensee BioMed Central Ltd. 2013
Received: 11 September 2012
Accepted: 28 January 2013
Published: 19 February 2013
Deep venous thrombosis (DVT) or pulmonary embolism (PE) is a rare, but not exceptional presentation of soft tissue sarcomas (STSs). Due to the remarkable difference in the incidence between DVT or PE and STSs, this type of STS presentation is usually associated with a considerable delay in tumor diagnosis and treatment.
We describe two cases of STS who presented with DVT and PE. Physical and radiographic examination only showed the presence of DVT. Both patients were treated for DVT or PE for several months. Due to the persistence of symptoms and the inefficacy of anticoagulant therapy, magnetic resonance imaging (MRI) was performed, which revealed the presence of a lower limb mass in both cases. The definite diagnosis was reached via excisional biopsy and histological examination.
In one case, MRI showed a large tumor in the anterior muscle compartment of the right thigh, with thrombosis of the right common femoral vein and involvement of the ipsilateral common iliac vein and inferior vena cava until the confluence of the renal veins. In the other case, MRI showed a large tumor in the middle third of the right thigh. The lesion was in close proximity to the superficial femoral vein that appeared compressed and showed signs of thrombosis. In both cases, histological examination revealed a high-grade leiomyosarcoma.
STSs of the lower extremities can rarely present with DVT or PE. This possibility should be considered in the differential diagnosis of painful leg swelling, especially in patients with recurrent or refractory venous thrombosis. When a STS is suspected, MRI should be obtained followed by excisional biopsy of the eventual mass. A delay in diagnosis and treatment of STSs often results in very poor prognosis.
Level of evidence. IV
KeywordsLeiomyosarcoma Venous thromboembolism Lower extremity sarcoma Pulmonary embolism
Sarcomas are relatively rare malignant tumors arising from the mesenchymal tissue, which encompasses muscle, fat, bone, blood vessels, and fibrous or other supporting tissue. Sarcomas display a wide variety of histological subtypes and frequently involve the limbs (55% of cases), especially the lower extremities [1–3].
The incidence of soft tissue sarcomas (STSs) is approximately 15-35 cases per million person-years, accounting for less than 1% of all malignancies [1–3]. About 3,200 new cases of STSs are diagnosed yearly in the U.K., while approximately 10,600 new cases were discovered in the U.S. in 2009 [4, 5]. The incidence of STSs increases steadily with age and is slightly higher in males than females. However, marked differences in age and sex distribution are seen depending on the histotype. For instance, rhabdomyosarcoma is more frequently observed in children and young adults, whereas synovial sarcomas typically affect young adult people. Malignant fibrous histiocytoma and liposarcoma generally occur in older adults [4, 5].
Overall, the risk of thromboembolic events in patients with STSs is comparable with that observed in other orthopedic conditions. However, STSs involving the hip or the thigh have been associated with a particularly high risk of thromboembolism .
Deep venous thrombosis (DVT) and venous thromboembolism (VTE) are common causes of morbidity and mortality especially in bedridden or hospitalized patients. In the U.S., the incidence of DVT is approximately 80-100 cases per 100,000 person-years . The risk of DVT increases with advancing age, ranging from less than 5 cases per 100,000 person-years in kids younger than 15 years to more than 500 cases per 100,000 person-years in 80+ year-old persons [7, 8]. DVT is responsible for about 600,000 hospitalizations yearly in the U.S. The in-hospital case-fatality rate for VTE is 12% and rises up to 21% in elderly individuals. The incidence of DVT is considerably higher in hospitalized patients compared with community-dwellings and varies from 20-70% [7, 8]. The risk of thromboembolic events is much greater in cancer patients relative to the general population [9, 10]. Indeed, patients with cancer are at 4- to 7-fold higher risk for VTE than those without cancer, with about 15% of cancer patients suffering at least a VTE episode. Notably, approximately 20% of patients presenting with VTE have an active cancer .
DVT is a rare, but not exceptional presentation of a STS. Due to the remarkable difference in the incidence of the two conditions, this type of presentation is usually associated with a considerable delay in the diagnosis and treatment of the tumor. In the present study, we describe 2 cases of STS of the lower limb, the onset of which was characterized by DVT and VTE. Because of the unusual presentation, in both cases diagnosis and treatment of the STS were significantly delayed. We also provide a concise review of the literature about the association between STSs and VTE.
Ethical approval was obtained by Ethical Committee of the Catholic University of Sacred Heart in Rome.
In the first case (Figure 1C-D), MRI showed a large mass in the anterior muscle compartment of the right thigh, with inhomogeneous appearance after gadolinium administration. The lesion was associated with multiple lymphadenopathy in the inguinal and external iliac region, and thrombosis of the right common femoral vein involving the ipsilateral common iliac vein and the inferior vena cava until the confluence of the renal veins. An excisional biopsy of the mass was performed. The lesion was found to be adherent to the femoral vein. The dissection of the vein showed a thrombus that obliterated the lumen of the common iliac vein. The histological examination revealed a high-grade leiomyosarcoma. The patient subsequently underwent chemotherapy and radiotherapy. A computerized tomography (CT) scan performed 6 months after surgery showed multiple pulmonary metastases. The patients is currently receiving chemotherapy in the Oncology division of our hospital.
In the second case, MRI showed a large mass located in the middle third of the right thigh, with low signal intensity in T1- and T2-weighted sequences and enhancement after gadolinium administration (Figure 2B-C-D-E-F). The lesion was in close proximity to the superficial femoral artery that appeared deformed and was adherent to the superficial femoral vein that appeared compressed and showed signs of thrombosis. After arterial embolization, an excisional biopsy was performed, followed by intraoperative brachytherapy. The histological examination of the bioptic specimen revealed a high-grade leiomyosarcoma. At one year of follow-up the patient was asymptomatic and showed no evidence of recurrence of malignancy at MRI.
Publications indexed in PubMed on STSs of the lower extremities associated with DVT, ordered according to the number of cases described
Total number of cases
Benns M et al. J Vasc Surg. ()
Malignant fibrous histiocytoma (3 cases)
Leiomyosarcoma (1 case)
Pleomorphic sarcoma (1) (1 case)
Arumilli et al. World J Surg [Oncol (2008])
Pleomorphic sarcoma (1 case)
Giant cell tumor ( 1 case)
Liposarcoma (1 case)
Emori M et al. Ann Vasc Surg. ()
Malignant fibrous histiocytoma (1 case)
Synovial sarcoma (1 case)
da Gama AD et al. Rev Port Cir Card [Vasc (2009])
Durant C et al. J Mal [Vasc (2009])
Subramaniam MM et al. Virchows Arch. ()
Sakpal SV et al. J Vasc Surg. ()
Calderelli GF et al. J Vasc Surg. ()
Shindo S et al. J Vasc Interv Radiol. ()
Tasci I et al. Clin Transl [Onc (2008])
Greenwald U et al. Ann Vasc [Surg (2004])
Carter RM et al. Clin [Radiol (2008])
Spindle cell sarcoma
Hoekstra HJ et al. Eur J Surg [Oncol (1997])
Minami S et al. J Orthop Sci. ()
Singh NK et al. [Phlebology (2009])
In a large case series of 5,234 patients treated for STSs, 19 cases exhibited the coexistence of STS and DVT (prevalence: 0.36%) . Among these patients, 6 cases (0.11%) were diagnosed with DVT before the STS had been discovered. In 3 cases, the histotype was malignant fibrous histiocytoma, whilst leiomyosarcoma, pleomorphic sarcoma and high-grade angiosarcoma were diagnosed in the remaining 3 cases . In 5 of these cases there was a delay in STS diagnosis ranging from one day to 12 months .
Arumilli et al.  describe 3 cases who presented with a painful swollen leg and were initially treated for DVT or Baker’s cyst, but were later diagnosed with a pleomorphic sarcoma, a malignant giant cell tumor of the muscle, and a myxoid liposarcoma. In another small case series, two cases of STSs of the inguinal region are described with compression of femoral vessels and venous obstruction . The condition resulted in signs and symptoms mimicking a DVT, including swelling, pain, and skin discoloration of the affected limb. Both patients were initially diagnosed with spontaneous DVT and administered unnecessary long-term anticoagulant therapy.
Other reports describe cases of leiomyosarcoma of the femoral vein, leiomyosarcoma involving the profunda femoris artery and the popliteal artery, fibular Ewing’s sarcoma, malignant epitheliod angiosarcoma, spindle cell sarcoma, pelvic and sacrum condrosarcoma, and liposarcoma [17–29]. In all these cases, patients presented with DVT of the lower extremity with initial misdiagnosis, delayed treatment, and poor outcome.
Both the presence of cancer and cancer treatment, including surgery and chemotherapy, are major risk factors for DVT. Indeed, approximately 18% of incident DVT cases can be attributed to an active malignant neoplasm . Remarkably, about 15% of pediatric or young adult patients with bone sarcomas or STSs develop thromboembolic events [31, 32]. Sarcomas located in the hip or the thigh are associated with a particularly high risk of thromboembolism . These observations indicate that DVT is a common event in patients affected by sarcomas of the lower extremities. In such circumstances, DVT may occur as a result of venous compression by the mass or due to a hypercoagulable state secondary to the production and secretion of procoagulant/fibrinolytic substances and inflammatory cytokines by cancer cells .
However, DVT is an unusual presentation STSs . The differential diagnosis between a thrombus and a STS by CT and MRI may be a challenging task, because imaging cannot easily distinguish a tumor thrombus from a blood clot. Furthermore, an organized thrombus usually shows low signal intensity on T1-and T2-weighted MRI sequences , which may be similar to the pattern evoked by a STS.
The two cases of leiomyosarcoma observed in our department support the notion that this histotype is the most frequently associated with unexplained DVT. The excision of the tumor followed by chemotherapy/radiotherapy or brachitherapy led to complete resolution of DVT and PE.
In conclusion, STSs are rare, yet potentially fatal malignancies characterized by local extension and occasional distant metastases. STSs of the lower extremities can present with VTE or mimic DVT, which may result in substantial delays in the diagnosis and treatment of the tumor. The two cases described here, together with our concise literature review, highlight the importance of considering the presence of neoplastic masses in the differential diagnosis of painful leg swelling conditions. In particular, STSs should be excluded in young patients with no risk factors for VTE and in those with recurrent or refractory thrombosis. In these cases, a careful physical examination together with imaging-assisted techniques (e.g., ultrasonography and MRI) are of utmost importance to promptly identify an eventual STS. Such an approach ensures the early diagnosis and management of STSs, which is essential to minimize morbidity and mortality [34–36].
Deep venous thrombosis
Magnetic resonance imaging
Soft tissue sarcoma
- Ilaslan H, Schils J, Nageotte W: Clinical presentation and imaging of bone and soft-tissue sarcomas. Cleve Clin J Med. 2010, 77 (Suppl 1): S2-S7.View ArticlePubMedGoogle Scholar
- What is sarcoma?.http://www.sarcoma.org.uk/what-is-sarcoma,
- Surgery for Bone and Soft-Tissue Tumors. Edited by: Simon MA, Springfield D. 1998, Philadelphia, PA: Lippincott-Raven, 198-200.Google Scholar
- Weiss SW, Goldblum JR, Enzinger FM: Enzinger and Weiss’ Soft Tissue Tumors. 2008, Philadelphia, PA: Mosby Elsevier, 5Google Scholar
- Jemal A, Siegel R, Ward E: Cancer statistics. CA Cancer J Clin. 2009, 59: 225-249. 10.3322/caac.20006.View ArticlePubMedGoogle Scholar
- Mitchell SY, Lingard EA, Kesteven P: Venous thromboembolism in patients with primary bone or soft-tissue sarcomas. J Bone Joint Surg Am. 2007, 89 (11): 2433-2439. 10.2106/JBJS.F.01308.View ArticlePubMedGoogle Scholar
- White RH: The epidemiology of venous thromboembolism. Circulation. 2003, 107: I-4-I-8.View ArticleGoogle Scholar
- Patel K: Deep Venous Thrombosis Treatment & Management.http://emedicine.medscape.com/article/1911303-overview,
- Pikó B, Kremer IM, Rahoty P: Thoughts about thromboembolic events prophylaxis in cancer patients. Magy Onkol. 2011, 55 (3): 164-169.PubMedGoogle Scholar
- Garcia D, Quintana D: Thrombosis and malignancy: a case-based review. Semin Hematol. 2011, 48 (4): 259-263. 10.1053/j.seminhematol.2011.08.006.View ArticlePubMedGoogle Scholar
- Agnelli G, Verso M: Management of venous thromboembolism in patients with cancer. J Thromb Haemost. 2011, 9 (Suppl 1): 316-324.View ArticlePubMedGoogle Scholar
- Booth AJ, Tweed CS: Fatal pulmonary embolism due to osteogenic sarcoma in a child. Clin Radiol. 1989, 40 (5): 533-535. 10.1016/S0009-9260(89)80279-X.View ArticlePubMedGoogle Scholar
- Soares FA: Fatal pulmonary tumor embolism caused by chondroblastic osteosarcoma. Arch Pathol Lab Med. 2000, 124 (5): 661-PubMedGoogle Scholar
- Benns M, Dalsing M, Sawchuck A: Soft tissue sarcomas may present with deep vein thrombosis. J Vasc Surg. 2006, 43 (4): 788-793. 10.1016/j.jvs.2005.12.039.View ArticlePubMedGoogle Scholar
- Arumilli BR, Lenin Babu V, Paul AS: Painful swollen leg – think beyond deep vein thrombosis or Baker's cyst. World J Surg Oncol. 2008, 18 (6): 6-View ArticleGoogle Scholar
- Emori M, Naka N, Hamada K: Soft-tissue sarcomas in the inguinal region may present as deep vein thrombosis. Ann Vasc Surg. 2010, 24 (7): 951-e7-951.e11View ArticlePubMedGoogle Scholar
- da Gama AD, Cabral G, Ministro A: Leiomyosarcoma of the superficial femoral vein. Case report. Rev Port Cir Cardiotorac Vasc. 2009, 16 (2): 97-101.PubMedGoogle Scholar
- Durant C, Connault J, Moreau A: Venous leiomyosarcoma mimicking deep venous thrombosis: contribution of positron emission tomography. J Mal Vasc. 2009, 34 (1): 50-53. 10.1016/j.jmv.2008.10.006.View ArticlePubMedGoogle Scholar
- Subramaniam MM, Martinez-Rodriguez M, Navarro S: Primary intravascular myxoid leiomyosarcoma of the femoral vein presenting clinically as deep vein thrombosis: a case report. Virchows Arch. 2007, 450 (2): 235-237. 10.1007/s00428-006-0322-2.View ArticlePubMedGoogle Scholar
- Sakpal SV, Mehta R, Babel N: Peripheral artery leiomyosarcoma. J Vasc Surg. 2009, 49 (1): 217-221. 10.1016/j.jvs.2008.07.018.View ArticlePubMedGoogle Scholar
- Caldarelli GF, Barellini L, Faviana P: Leiomyosarcoma of the popliteal artery: case report and review of the literature. J Vasc Surg. 2003, 37 (1): 206-209. 10.1067/mva.2003.83.View ArticlePubMedGoogle Scholar
- Shindo S, Katsu M, Kaga S: Leiomyosarcoma of a Femoral Vein Misdiagnosed as Deep Vein Thrombosis. Clin Transl Oncol. 2008, 10 (12): 847-849. 10.1007/s12094-008-0300-z.View ArticleGoogle Scholar
- Tasci I, Erdem G, Dogru T: Ewing's sarcoma of the fibula presenting with venous thrombosis. Clin Transl Oncol. 2008, 10 (12): 847-849. 10.1007/s12094-008-0300-z.View ArticlePubMedGoogle Scholar
- Greenwald U, Newman E, Taneja S: Malignant epithelioid angiosarcoma of the external iliac vein presenting as venous thrombosis. Ann Vasc Surg. 2004, 18: 493-496. 10.1007/s10016-004-0067-9.View ArticlePubMedGoogle Scholar
- Carter RM, Uthappa MC, Warakaulle DR: Case report: spindle cell sarcoma of the profunda femoris vein mimicking deep venous thrombosis. Clin Radiol. 2008, 63 (2): 231-235. 10.1016/j.crad.2007.07.019.View ArticlePubMedGoogle Scholar
- Obuobie K, Roach H, Harvey J: An abnormal venous clot. Lancet. 2001, 357: 1334-10.1016/S0140-6736(00)04521-9.View ArticlePubMedGoogle Scholar
- Hoekstra HJ, Pras B, Mooyaart EL: Pelvic girdle chondrosarcoma and inferior vena cava thrombosis. Eur J Surg Oncol. 1997, 23 (6): 577-579. 10.1016/S0748-7983(97)93589-7.View ArticlePubMedGoogle Scholar
- Minami S, Kounami S, Sakata R: Chondrosarcoma of sacrum presenting with a deep vein thrombosis. J Orthop Sci. 2011, 16 (4): 482-486. 10.1007/s00776-011-0057-z.View ArticlePubMedGoogle Scholar
- Singh NK, Kolluri R: Liposarcoma of thigh presenting as deep venous thrombosis. Phlebology. 2009, 24 (3): 139-141. 10.1258/phleb.2009.008077.View ArticlePubMedGoogle Scholar
- Heit JA, O’Fallon M, Petterson TM: Relative impact of risk factors for deep vein thrombosis and pulmonary embolism. Arch Intern Med. 2002, 162: 1245-1248. 10.1001/archinte.162.11.1245.View ArticlePubMedGoogle Scholar
- Athale U, Cox S, Siciliano S: Thromboembolism in children with sarcoma. Pediatr Blood Cancer. 2007, 49 (2): 171-176. 10.1002/pbc.21047.View ArticlePubMedGoogle Scholar
- Paz-Priel I, Long L, Helman LJ: Thromboembolic events in children and young adults with pediatric sarcoma. J Clin Oncol. 2007, 25 (12): 1519-2412. 10.1200/JCO.2006.06.9930.View ArticlePubMedGoogle Scholar
- De Cicco M: The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol. 2004, 50: 187-196. 10.1016/j.critrevonc.2003.10.003.View ArticlePubMedGoogle Scholar
- Zagars GK, Ballo MT, Pisters PW: Prognostic factors for patients with localized soft-tissue sarcoma treated with conservative surgery and radiation therapy: an analysis of 225 patients. Cancer. 2003, 97: 2530-2543. 10.1002/cncr.11365.View ArticlePubMedGoogle Scholar
- Pisters PW, Leung DH, Woodruff J: Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996, 14: 1679-1689.PubMedGoogle Scholar
- Weitz J, Antonescu C, Brennan M: Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol. 2003, 21: 2719-2725. 10.1200/JCO.2003.02.026.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/14/64/prepub